BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35498155)

  • 21. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
    Mei J; Zhu C; Pan L; Li M
    Bioengineered; 2022 Jan; 13(1):61-70. PubMed ID: 34939526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
    Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
    J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
    Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
    Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
    Duan L; Yang Z; Jiang X; Zhang J; Guo X
    Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-542 inhibits tumorigenesis and chemoresistance through the AKT/NFκB pathway in cervical cancer.
    Liu QH; Li HL; Zhang H; Li Z; Zhao M; Zhang TT
    J Biol Regul Homeost Agents; 2020; 34(5):1809-1817. PubMed ID: 33153258
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein.
    Li YL; Zhao YG; Chen B; Li XF
    Pharmazie; 2016 Dec; 71(12):715-718. PubMed ID: 29442000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.
    Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X
    BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
    Shu XR; Wu J; Sun H; Chi LQ; Wang JH
    Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
    Yu S; Wu C; Tan Q; Liu H
    J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
    Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
    Han J; Hu X
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway.
    Su D
    Immunopharmacol Immunotoxicol; 2022 Feb; 44(1):17-27. PubMed ID: 34821526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.